Literature DB >> 552898

Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.

J Gold.   

Abstract

Clofibrate as a sole agent was found to have statistically perceptible antitumor effects against the in vivo growth of Walker 256 intramuscular carcinosarcoma in rats. Clofibrate was also found to potentiate the antitumor effect of hydrazine sulfate, cytotoxic drugs and the combination of hydrazine sulfate + cytotoxic drug. The results suggest that substances which might directly or indirectly interfere with host lipogenesis and/or lipolysis, may also have adjunctal antitumor potential.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 552898

Source DB:  PubMed          Journal:  Cancer Biochem Biophys        ISSN: 0305-7232


  2 in total

Review 1.  Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-05-19       Impact factor: 8.262

2.  Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues.

Authors:  M J Tisdale; R A Brennan
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.